TrialBritish journal of cancer2006

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

M Guzmán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.